Abstract
We aimed to evaluate the effect of in vitro galactosaemia on acetylcholinesterase (AChE) activity in different suckling rat brain regions. Various concentrations of galactose (Gal), galactose-1-phosphate (Gal-1-P) and/or galactitol (Galtol) were preincubated for 1 h with homogenates from frontal cortex, hippocampus and for 1–3 h with hypothalamus homogenates at 37∘C. AChE activity was determined spectrophotometrically. Mixture A {Gal-1-P (2 mM), Galtol (2 mM), and Gal (4 mM) (=brain concentrations in classical galactosaemia)} or mixture B {Galtol (2 mM) and Gal (1 mM) (=brain concentrations in galactokinase deficiency galactosaemia)} inhibited by 18–20% (P < 0.01) AChE activity in frontal cortex or hippocampus homogenates. Gal-1-P (2–8 mM) reduced AChE activity by 20% (P < 0.01) on frontal cortex and hippocampus homogenates. Galtol (2–8 mM) resulted in an AChE inhibition {20–22% (P < 0.01)} in hippocampus, 2 mM of the substance had the same effect (20%, P < 0.01) on frontal cortex, whereas higher concentrations (4–8 mM) failed to decrease the enzyme activity anymore. Gal (1–8 mM) did not change AChE activity in the studied areas. Additionally, the hypothalamus enzyme activity was measured considerably high and remained unaltered in the presence of the above compounds. In conclusion, AChE activity was significantly higher in hypothalamus compared with those in frontal cortex and hippocampus. Frontal cortex and hippocampus AChE was significantly inhibited by Gal derivatives, whereas hypothalamus AChE activity remained unaltered possibly due to the histologically different innervation of this area.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berry, G.T., and Segal, S. (2000). Disorders of galactose metabolism. In (C.R. Scriver, A.L. Beadet, W.S. Sly, and D. Valle, eds.), The Metabolic and Molecular Basis of Inherited Disorders, McGraw-Hill, New York, pp. 1553–1589.
Committee on Care and Use of Laboratory Animals (1985). Guide for the Care and Use of Laboratory Animal, Institute of Laboratory Animals Resources, National Research Council, Washington, DC, p. 83.
Doulgeraki, A., Papadopoulou-Daifoti, Z., and Tsakiris, S. (2002). Effects of L-Phenylalanine on acetylcholinesterase and Na+/K+-ATPase activities in suckling rat frontal cortex, hippocampus, and hypothalamus. Z. Naturforsch. 57c:182–188.
Ellman, G.L., Courtney, D., Andres, V., and Featherstone, R.M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88–95.
Grisaru, D., Sternfeld, M., Eldor, A., Glick, D., and Hermona, S. (1999). Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264:672–676.
Guyton, A.C. (2000). Textbook of Medical Physiology, WB Saunders, Philadelphia, PA, pp. 1553–1589.
Hansen, T.W.R., Henrichsen, B., Rasmussen, R.K., Carling, A., Andreassen, A.B., and Skjeldal, O. (1996). Neuropsychological and linguistic follow-up studies of children with galactosemia from an unscreened population. Acta Paediatr. 85:1197–1201.
Hommes, F.A. (1993). The effect of hyperphenilalaninemia on the muscarinic acetylcholine receptor in the HPH-5 mouse brain. J. Inherit. Metab. Dis. 6:32–35.
Karikas, C.A., Schulpis, K.H., Tsakiris, S., Tjamouranis, J., and Georgala, S. (1999). In vitro effect of galactose-1-phosphate on acetylcholinesterase activity. Res. Commun. Biol. Psychol. 24:55–58.
Kolb, B. (1984). Functions of the frontal cortex of the rat: A comparative review. Brain Res. Rev. 8:65–98.
Kouniniotou-Krontiri, P. (1985). Effects du lithium sur la liberation quantique spontanee de transmetteur par les terminaisons motrices du diaphragm de rat. J. Physiol. (Paris) 80:340–348.
Kouniniotou-Krontiri, P., and Tsakiris, S. (1989). Time depedence of Li+ action on acetylcholinesterase activity in correlation with spontaneous quantal release of acetylcholine in rat diaphragm. Jpn. J. Physiol. 39:429–440.
Lotti, M. (1995). Cholinesterase inhibition complexes in the interpretation. Clin. Chem. 4:1814–1818.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Ostle, B. (1954). Statistics in Research, Iowa State University Press, Iowa, IA, pp. 110–126.
Satoh, K., Staines, W.A., Atmadja, S., and Fibigen, H.C. (1983). Unstructural observation of the cholinergic neuron in rat striatum as identified by acetylcholinesterase pharmacochemistry. Neuroscience 10:1121–1136.
Schulpis, K.H., Papaconstantinou, E.D., Michelakakis, H., and Shin, Y. (1997). Screening for galactosemia in Greece. Pediatr. Perinatal. Epidemiol. 11:436–440.
Segal, S. (1998). Galactosemia today: The enigma and the challenge. J. Inherit. Metab. Dis. 45:455–457.
Shim, I., Chung, J.Y., Lee, H.J., Yang, K.H., and Chang, J.H. (2003). Association of learning and memory impairments with changes in the septohippocampal cholinergic system in rats with kaolin-induced hydrocephalus. Neurosurgery 53:416–425.
Shin-Buehring, V.S., Beier, T., Tan, A., Osang, M., and Schanb, J. (1977). The activity of galactose-1-phosphate uridyl transferase and galactokinase in human fetal organs. Pediatr. Res. 11:1003–1009.
Sussman, J.-L., Hamel, M., Filow, F., and Goodman, A. (1991). Atomic structure of acetylcholinetserase. Science 253:872–880.
Thal, L.G., Gilbertson, E., and Armstrong, D.M. (1991). Development of the basal forebrain system, phenotype expression prior to target innervation. Neurobiol. Aging 13:61–72.
Thomas, W. (1986). Studies of neurotransmitter chemistry of central nervous system neurons in primary tissue culture. Life Sci. 38:297–308.
Tsakiris, S., Angelogianni, P., Schulpis, K.H., and Stavridis, J.C. (2000). Protective effect of L-Phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin. Biochem. 33:103–106.
Tsakiris, S., Marinou, K., and Schulpis, K.H. (2002). The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity. Pharmacol. Toxicol. 91:254–257.
Tsakiris, S., and Schulpis, K.H. (2000). The effect of galactose metabolic disorders on the rat brain acetylcholinesterase activity. Z. Naturforsch. 55c:852–855.
Tsakiris, S., Schulpis, K.H., Marinou, K., and Behrakis, P. (2004). Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+,K+-ATPase and Mg2+-ATPase activities induced by the in vitro galactosemia. Pharmacol. Res. 49:475–479.
Vincent, S., Satoh, K., and Fibiger, H. (1986). The localization of central cholinergic neurons. Prog. Neuropsychopharmacol. Biol. Psychiatry 10:637–656.
Waggoner, D.D., Buist, N.M.R., and Donnell, G.N. (1990). Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J. Inherit. Metab. Dis. 13:802–818.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marinou, K., Tsakiris, S., Tsopanakis, C. et al. Suckling Rat Brain Regional Distribution of Acetylcholinesterase Activity in Galactosaemia In Vitro. Metab Brain Dis 20, 227–236 (2005). https://doi.org/10.1007/s11011-005-7210-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11011-005-7210-3